Skip to content

Clinical trials

Completed Carcinoma, Merkel Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Merkel Cell Status: Completed Country / region: United States Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20091
20102
20121
20143
20151
20164
20173
20184
20195
20202
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
Incyte Biosciences International Sàrl3
Incyte Corporation3
AbbVie2
Memorial Sloan Kettering Cancer Center2
Arcus Biosciences, Inc.1
Claire Verschraegen1
Dan Zandberg1
Dana-Farber Cancer Institute1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Merkel Cell36
Melanoma16
Carcinoma, Non-Small-Cell Lung12
Stomach Neoplasms11
Uterine Cervical Neoplasms11
Carcinoma, Hepatocellular10
Carcinoma, Renal Cell10
Small Cell Lung Carcinoma10
Ovarian Neoplasms9
Mesothelioma8

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.